Brachytherapy Devices Market Analysis and Opportunities by 2031

[Research Report] The brachytherapy devices market is expected to grow from US$ 343.57 million in 2024 to US$ 534.20 million by 2031; it is estimated to register a CAGR of 6.7% from 2025 to 2031.

Analyst Viewpoint

Brachytherapy, also known as internal radiation therapy (IRT), involves inserting radioactive devices such as seeds, ribbons, wires, needles, capsules, balloons, or tubes near tumors to deliver high doses of radiation. This treatment is effective in eliminating and shrinking tumors. Brachytherapy is distinct from other forms of radiation therapy because it allows for administering higher doses of radiation while minimizing damage to surrounding organs. The growing prevalence of cancers is a major factor augmenting the brachytherapy devices market growth. Additionally, technological advancements and the rise in the adoption of IRTs for cancer management are contributing to the market growth. However, risks associated with brachytherapy and a lack of skilled technicians hamper the market growth.

Market Insights

The increasing prevalence of cancers, including breast cancer, prostate cancer, and cervical cancer, propels the brachytherapy devices market size. According to the statistics published by the World Health Organization (WHO) in February 2024, ~ 20 million new cases of cancer and 9.7 million deaths were reported globally in 2022. Among these cases, breast cancer is the most common type of cancer, with 2.3 million cases diagnosed in women. In addition, prostate and colorectal cancers are the second and third most commonly occurring cancers in men. Brachytherapy devices are frequently used to treat gynecologic, prostate, breast, and other types of cancer effectively. These devices include wires, seeds, or rods filled with radioactive materials implanted near the tumor to treat it by emitting radiation for a specified distance.

Moreover, brachytherapy is less time-consuming and has fewer side effects than other radiation therapies. According to an article published by Elsevier in June 2023, the study aimed to compare the results of brachytherapy over external beam radiation therapy (EBRT) by collecting a large multi-institutional database, concluded that the use of brachytherapy devices has been linked with improved survival rates and a reduced incidence of distant cancer metastases as compared to EBRT. This finding is significant and could encourage the adoption of brachytherapy as a cost-effective and efficient treatment option for patients who have intermediate- to high-risk prostate cancer.

Therefore, as the prevalence of cancer continues to rise globally, the demand for brachytherapy as a widely accessible treatment option contributes significantly to boosting brachytherapy devices market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Brachytherapy Devices Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Report Segmentation and Scope

The “brachytherapy devices market analysis” has been carried out by considering the following segments: product type, type, application and end user.

The market, by product type, is segmented seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. Bytype, the market is bifurcated into high-dose rate brachytherapy implant and low-dose rate brachytherapy implant. The market, by application, is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others.

The market, by end user, is segmented into hospitals and specialty clinics, ambulatory surgical centers, and others.

The scope of the global brachytherapy devices market report entails North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Product Type-Based Insights

Based on product type, the brachytherapy devices market is segmented into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders and applicators segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.

Type-Based Insights

The market, by type, is bifurcated into high-dose brachytherapy implant and low-dose rate brachytherapy implant. The low-dose rate brachytherapy implant segment held a larger brachytherapy devices market share in 2022 and is anticipated to grow at a faster CAGR from 2022 to 2030.

Application-Based Insights

The brachytherapy devices market, by application, is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.

End User-Based Insights

Based on end user, the market is segmented into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022. This can be attributed to the availability of better facilities and skilled physicians in hospitals over other surgical centers to perform minimally invasive procedures.

Regional Analysis

Based on geography, the market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. In terms of revenue, North America dominated the brachytherapy devices market share in 2022. The brachytherapy devices market in this region is dominated by the US. This can be attributed to various factors, including the increasing cases of breast cancer among women and prostate cancer among men in the region. According to the Pan America Health Organization (PAHO), in 2020, an estimated 4 million people in the Americas were diagnosed with cancer, which is predicted to increase by ~60% by 2040.

Additionally, the presence of market players, including BD, Isoray Inc., and Elekta, and the availability of advanced brachytherapy devices present a sizable opportunity for the market expansion. For instance, in July 2021, GenesisCare expanded its brachytherapy service by procuring 27 Flexitron brachytherapy afterloader systems and service agreements from Elekta. These advanced cancer treatment devices enabled GenesisCare to keep up with the latest technology and provide high-quality care to its patients across their centers in the US.

Brachytherapy Devices Market Regional Insights

The regional trends and factors influencing the Brachytherapy Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Brachytherapy Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Brachytherapy Devices Market Report Scope

Brachytherapy Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Brachytherapy Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Brachytherapy Devices Market are:

1. Elekta
2. Varian Medical Systems, Inc.
3. BEBIG Medical
4. Theragenics Corporation
5. IsoAid
6. Siemens Healthineers AG

Disclaimer: The companies listed above are not ranked in any particular order.

Industry Developments and Future Opportunities:

The brachytherapy devices market forecast can help stakeholders in this marketplace plan their growth strategies. As per company press releases, a few strategic developments by leading players operating in the global market are listed below:

• In October 2023, Elekta announced acquisition of the Xoft business from iCAD, Inc. through an asset acquisition. By acquiring the Xoft Axxent Electronic Brachytherapy (eBx) System, along with the transfer of employees, the company aims to provide an expanded range of cancer treatment options and electronic brachytherapy technology.
• As per the press release in July 2023, CIVCO Radiotherapy announced its partnership with Qfix, a company that provides devices for positioning and immobilizing patients, during the American Society for Radiation Oncology (ASTRO) Annual Meeting held from October 23–26, 2022 in San Antonio, Texas.
• In July 2022, BEBIG Medical acquired Wolf-Medizintechnik GmbH (WOmed), a German company that supplies cutting-edge X-ray therapy and newly developed intraoperative radiation therapy products to the global market. The acquisition aimed to expand BEBIG Medical's product portfolio in radiation therapy for cancer treatment.
• In December 2020, Varian Medical Systems, Inc, launched four new brachytherapy applicator sets for HDR brachytherapy of vagina, cervix, uterus, endometrium, and rectum. The new suite of applicators is designed to address issues of applicator size, ease of use, and MRI imaging support. This new addition is made more user-friendly and comfortable for patients, allowing clinicians to treat more patients on an outpatient basis.

Elekta; Varian Medical Systems, Inc.; BEBIG Medical; Theragenics Corporation; IsoAid; Siemens Healthineers AG; BXTA; BD; Eckert and Ziegler; and Perspective Therapeutics are some of the key companies profiled in the brachytherapy devices market report. These leading players focus on expanding and diversifying their market presence and clientele, tapping business opportunities in the market.